0000126524 00000 n
0000047988 00000 n
0000127857 00000 n
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care. 0000129218 00000 n
A1–A2, S1–S46 (October 2020) View all issues. I am passionate, enthusiastic, and driven to help conquer the stigma against obesity; educate health care professionals and the public about obesity, diabetes, and healthy living; and to help us become a healthier society! They suggest that if a person is at A1C target but could benefit from these medications, that switching an existing diabetes medication for one of these meds (rather than adding the medication on top) may be appropriate. Canadian Diabetes Association 2013 Guidelines are Out! As to whether we can skip metformin at initial diagnosis of diabetes if a person has pre-existing cardiovascular disease, heart failure, or chronic kidney disease, the User’s Guide advises that this approach ‘may be considered’. 493 135
Diabetes Canada leads the fight against diabetes by helping those affected by diabetes live healthy lives, preventing the onset and consequences of diabetes, and discovering a cure. 0000054077 00000 n
0000038166 00000 n
Major credit cards (American 0000128894 00000 n
The 5 R’s of diabetes care Diabetes Care 2020;43(Suppl. If your patient has cardiovascular disease, is age over 60 at high risk of cardiovascular disease, or has heart failure or kidney disease, medications from the SGLT2i and GLP1RA classes are recommended based on the clinical trial evidence. After completing my training as an Endocrinologist in 2005 at the University of Calgary, I have worked in Calgary, at the Royal University Hospital in Saskatchewan, and at the University of Copenhagen in Denmark. 0000124261 00000 n
The User’s Guide points out that some recent trials have included patients at A1C target, showing benefit for reduction in heart failure and cardiovascular death in people with heart failure (SGLT2i), and reduction in cardiovascular events for people with , or at high risk for, cardiovascular disease (GLP1RA). I have been involved as an investigator in clinical trials of GLP1 receptor agonists and SGLT2 inhibitors. 0000054510 00000 n
0000007099 00000 n
Search. We use cookies to ensure that we give you the best experience on our website. The full Diabetes Canada Clinical Practice Guidelines were last published in 2018, and many important clinical trials have been published since then which have significantly changed how we approach treatment of type 2 diabetes. 0000021175 00000 n
Before adding bolus (mealtime) insulin, it is recommended to consider other medications (GLP1, SGLT2i, or DPP4i) before moving on to add mealtime insulin. Guideline Homepage: ADA 2020 Standards of Medical Care in Diabetes – American Diabetes Association (free supplement) Commentaries: ADA 2020 Standards of Care Incorporate CVD Risk Stratification, New Medications – Endocrinology Advisor (free) AND ADA releases 2020 standards of medical care in diabetes – University of North Carolina at Chapel Hill School of Medicine (free) %PDF-1.7
%����
0000003877 00000 n
I am a member of the Expert Committee for the 2018 Diabetes Canada Guidelines, and an author on the upcoming Canadian Obesity Guidelines. 0000128004 00000 n
0000125024 00000 n
0000010963 00000 n
*The Canadian Diabetes Association is the registered owner of the name Diabetes Canada. About the journal. 0000047002 00000 n
0000007574 00000 n
0000006048 00000 n
0000003640 00000 n
Ottawa: Diabetes Canada; 2020. 0000126291 00000 n
They promote healthy eating and overall nutritional well-being, and support improvements to the Canadian food environment. Click here for the saveable and printable pdf. The Standards are developed by the ADA’s multidisciplinary Professional Practice Committee, which comprises physicians, diabetes educators, and other expert diabetes health care professionals. 0000124481 00000 n
Does Metformin protect against severe COVID-19 infection? 0000007764 00000 n
View our Privacy Policy. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (2013) ... ADA and EASD Consensus Report (2020) Diabetes digital app technology: benefits, challenges, and recommendations. The Kidney Disease: Improving Global Outcomes (KDIGO) 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents the first KDIGO guideline on this subject. xref
• Processing Fee: A non-refundable processing will be charged for each abstract submitted. 0000125579 00000 n
Payment must be made by a credit card. 0000126717 00000 n
Clinical resources. View PDF here. Guidelines … Copyright DrSue.ca Designated trademarks and brands are the property of their respective owners. All NICE products on diabetes. DIABETES CANADA AND CSEM ABSTRACT GUIDELINES Diabetes Canada and the Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference will be held in Calgary, Alberta from October 28-31, 2020. If you have a medical problem you should consult your own physician for advice specific to your own situation. The number of people with diabetes is rising, both in Canada and around the world. 0000010789 00000 n
0000127019 00000 n
0000003919 00000 n
0000032228 00000 n
0000126637 00000 n
Related Content Clinical Practice Guidelines. 627 0 obj
<>stream
0000004825 00000 n
0000073118 00000 n
They recommend adding to metformin with additional medication if glycemic targets are not achieved, or the individual’s clinical status changes (eg should heart disease, kidney disease or heart failure manifest). The 5 R’s describe the key components to consider for organizing diabetes care in the office or clinic. 0000005620 00000 n
trailer
Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. After completing my training as an Endocrinologist in 2005 at the University of Calgary, I have worked in Calgary, at the Royal University Hospital in Saskatchewan, and at the University of Copenhagen in Denmark. Guide for authors. *NEW* This quick reference guide includes key topics and decision support from the 2018 Clinical Practice Guidelines (Updated for 2020). <<333061D96E08D041A4BCC23292565D57>]>>
0000006865 00000 n
0000006554 00000 n
0000054263 00000 n
0000127373 00000 n
Our clinical tools, resources and guidelines chapters are designed to support diabetes prevention, diagnosis, care, and management. Subscribe to the Diabetes Canada podcast for a 360° view of diabetes every two weeks. Diabetes Canada Diabetes Charter. 0000126447 00000 n
Disclaimer: I receive honoraria as a continuing medical education speaker and consultant from the makers of SGLT2 inhibitors and GLP1 receptor agonists. 0000013919 00000 n
The resulting identified key messages for FPs to consider … 0000012413 00000 n
0000123504 00000 n
Full-Text HTML; PDF Appendices. The Diabetes Canada/CSEM Program Committee invites abstract submissions for consideration. 0000048394 00000 n
0000048563 00000 n
Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update: 2018 Guidelines. pp. 0000123059 00000 n
Methods The overarching goals and methodologic principles for the Diabetes Canada CPG are unchanged from 2018 (2,3). Quality of evidence A prioritization process was conducted to focus the efforts of Diabetes Canada’s guideline dissemination and implementation efforts. About our podcast - Diabetes Canada podcast. The 2020 Canadian Adult Obesity Clinical Practice Guidelines (all 19 chapters here) were written as a desperately needed update from the last obesity guidelines, which were published in 2006. 0000038580 00000 n
Canadian Obesity Guidelines. Highlights from the Canadian Chronic Disease Surveillance System. 0000010492 00000 n
0000023972 00000 n
Welcome to the Hypertension Canada Guidelines Website. 0000008238 00000 n
• Processing Fee: A non-refundable processing will be charged for each abstract … I have a busy clinical practice at C-ENDO Diabetes and Endocrinology Clinic in Calgary, caring for patients with diabetes, obesity, thyroid, and other hormone issues. 0000008308 00000 n
Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update — The User’s Guide. Developed by an expert volunteer network, the Guidelines are evidence-based, rigorously reviewed, and updated regularly to keep Canada’s health care professionals informed of best-practices in hypertension management.